Trial · NCT07896252
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Bronchodilation - FEV1 | Change from baseline in FEV1 at 24 hours post-dose on Days 1 and 14 | |
| Primary | Bronchodilation - FEV AUC | Change from baseline in FEV1 AUC(0-24 hours) on Days 1 and 14 | |
| Primary | Bronchodilation - Peak FEV1 | Peak change in FEV1 within 4 hours post-dose on Days 1 and 14 | |
| Primary | Bronchodilation - time to onset of FEV1 >100mL | Change in FEV1 >100mL from pre-dose on Days 1 and 14 | |
| Secondary | Pharmacokinetics - Cmax | 0-24 hours on Days 1 and 14 | Cmax (maximum plasma concentration) |
| Secondary | Pharmacokinetics - AUC | AUC(0-6 hours) on Days 1 and 14 | AUC (area under the plasma concentration) |
| Secondary | Pharmacokinetics - Tmax | Tmax on Days 1 and 14 | Tmax (time to maximum concentration) |
| Secondary | Treatment-emergent adverse events (TEAEs) | Up to approximately Day 14 | Number of participants with TEAEs |
| Secondary | Blood Pressure | Up to approximately Day 14 | Number of participants with markedly abnormal changes in Blood Pressure |
| Secondary | Heart Rate | Up to approximately Day 14 | Number of participants with markedly abnormal changes in Heart Rate |
| Secondary | 12-lead ECG - QT Interval corrected for Heart Rate Using Fridericia's Formula (QTcF) | Up to approximately Day 14 | Number of participants with markedly abnormal changes in QTcF |
| Secondary | Clinical laboratory - Hematology | Up to approximately Day 14 | Number of participants with markedly abnormal changes in hematology parameters |
| Secondary | Clinical laboratory - Blood Chemistry | Up to approximately Day 14 | Number of participants with markedly abnormal changes in blood chemistry parameters |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07896252/registered